Market Overview:
The North Africa Generic drug market is currently witnessing strong growth. A generic drug is a medication with the same active ingredients as a branded drug. It is identical in terms of quality, strength, dosage, performance, and efficiency. Moreover, it offers similar therapeutic effects at a substantially low cost. Therefore, its demand is escalating in the North African region.
The burgeoning pharmaceutical industry represents one of the major factors strengthening the growth of the generic drugs market in the North African region. Moreover, governing agencies are introducing price control policies and import restrictions to encourage domestic drug manufacturing in the region. This, in turn, is strengthening the growth of the generic drugs market. Other factors adding to the generic drug market growth are the rising prevalence of non-communicable diseases and increasing healthcare costs. However, the surging cases of coronavirus disease (COVID-19) and the imposition of lockdown restrictions across the region have disrupted the production of generic drugs. This has negatively affected the market, but it is anticipated to witness growth once lockdown restrictions are uplifted in the region and the production process acquires pace. Looking forward, the market is expected to continue its strong growth during the forecast period (2021-2026).
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the North Africa Generic drug market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, segment, therapy area, drug delivery and distribution channel.
Breakup by Segment:
- Unbranded Generics
- Branded Generics
Breakup by Therapy Area:
- Central Nervous System
- Cardiovascular
- Dermatology
- Genitourinary/Hormonal
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
Breakup by Drug Delivery:
- Oral
- Injectables
- Dermal/Topical
- Inhalers
Breakup by Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
Breakup by Country:
- Algeria
- Egypt
- Libya
- Morocco
- Tunisia
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key Questions Answered in This Report:
- How has the North Africa generic drug market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the North Africa generic drug market?
- What are the key regional markets?
- What is the breakup of the market based on the segment?
- What is the breakup of the market based on the therapy area?
- What is the breakup of the market based on the drug delivery?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the market?
- What is the structure of the North Africa generic drug market and who are the key players?
- What is the degree of competition in the market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 North Africa Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Segment
6.1 Unbranded Generics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Branded Generics
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Country
10.1 Algeria
10.1.1 Market Trends
10.1.2 Market Breakup by Segment
10.1.3 Market Breakup by Therapy Area
10.1.4 Market Breakup by Drug Delivery
10.1.5 Market Breakup by Distribution Channel
10.1.6 Market Forecast
10.2 Egypt
10.2.1 Market Trends
10.2.2 Market Breakup by Segment
10.2.3 Market Breakup by Therapy Area
10.2.4 Market Breakup by Drug Delivery
10.2.5 Market Breakup by Distribution Channel
10.2.6 Market Forecast
10.3 Libya
10.3.1 Market Trends
10.3.2 Market Breakup by Segment
10.3.3 Market Breakup by Therapy Area
10.3.4 Market Breakup by Drug Delivery
10.3.5 Market Breakup by Distribution Channel
10.3.6 Market Forecast
10.4 Morocco
10.4.1 Market Trends
10.4.2 Market Breakup by Segment
10.4.3 Market Breakup by Therapy Area
10.4.4 Market Breakup by Drug Delivery
10.4.5 Market Breakup by Distribution Channel
10.4.6 Market Forecast
10.5 Tunisia
10.5.1 Market Trends
10.5.2 Market Breakup by Segment
10.5.3 Market Breakup by Therapy Area
10.5.4 Market Breakup by Drug Delivery
10.5.5 Market Breakup by Distribution Channel
10.5.6 Market Forecast
10.6 Others
10.6.1 Market Trends
10.6.2 Market Breakup by Segment
10.6.3 Market Breakup by Therapy Area
10.6.4 Market Breakup by Drug Delivery
10.6.5 Market Breakup by Distribution Channel
10.6.6 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Policy and Regulatory Landscape
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
List of Figures
Figure 1: North Africa: Generic Drug Market: Major Drivers and Challenges
Figure 2: North Africa: Generic Drug Market: Sales Value (in Million US$), 2015-2020
Figure 3: North Africa: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: North Africa: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 5: North Africa: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 6: North Africa: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 7: North Africa: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 8: North Africa: Generic Drug Market: Breakup by Country (in %), 2020
Figure 9: North Africa: Generic Drug (Unbranded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: North Africa: Generic Drug (Unbranded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: North Africa: Generic Drug (Branded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: North Africa: Generic Drug (Branded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: North Africa: Generic Drug (Central Nervous System) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: North Africa: Generic Drug (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: North Africa: Generic Drug (Cardiovascular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: North Africa: Generic Drug (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: North Africa: Generic Drug (Dermatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: North Africa: Generic Drug (Dermatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: North Africa: Generic Drug (Genitourinary/Hormonal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: North Africa: Generic Drug (Genitourinary/Hormonal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: North Africa: Generic Drug (Respiratory) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: North Africa: Generic Drug (Respiratory) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: North Africa: Generic Drug (Rheumatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: North Africa: Generic Drug (Rheumatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: North Africa: Generic Drug (Diabetes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: North Africa: Generic Drug (Diabetes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: North Africa: Generic Drug (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: North Africa: Generic Drug (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: North Africa: Generic Drug (Other Therapy Areas) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: North Africa: Generic Drug (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: North Africa: Generic Drug (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: North Africa: Generic Drug (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: North Africa: Generic Drug (Injectables) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: North Africa: Generic Drug (Injectables) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: North Africa: Generic Drug (Dermal/Topical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: North Africa: Generic Drug (Dermal/Topical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: North Africa: Generic Drug (Inhalers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: North Africa: Generic Drug (Inhalers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: North Africa: Generic Drug (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: North Africa: Generic Drug (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: North Africa: Generic Drug (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: North Africa: Generic Drug (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Algeria: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Algeria: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 45: Algeria: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 46: Algeria: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 47: Algeria: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 48: Algeria: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Egypt: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Egypt: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 51: Egypt: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 52: Egypt: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 53: Egypt: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 54: Egypt: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Libya: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Libya: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 57: Libya: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 58: Libya: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 59: Libya: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 60: Libya: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Morocco: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Morocco: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 63: Morocco: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 64: Morocco: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 65: Morocco: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 66: Morocco: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Tunisia: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Tunisia: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 69: Tunisia: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 70: Tunisia: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 71: Tunisia: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 72: Tunisia: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Others: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Others: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: North Africa: Generic Drug Industry: SWOT Analysis
Figure 76: North Africa: Generic Drug Industry: Value Chain Analysis
Figure 77: North Africa: Generic Drug Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: North Africa: Generic Drug Market: Key Industry Highlights, 2020 and 2026
Table 2: North Africa: Generic Drug Market Forecast: Breakup by Segment (in Million US$), 2021-2026
Table 3: North Africa: Generic Drug Market Forecast: Breakup by Therapy Area (in Million US$), 2021-2026
Table 4: North Africa: Generic Drug Market Forecast: Breakup by Drug Delivery (in Million US$), 2021-2026
Table 5: North Africa: Generic Drug Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: North Africa: Generic Drug Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 7: North Africa: Generic Drug Market: Key Players